Join to View Full Profile
12902 Usf Magnolia DrTampa, FL 33612
Phone+1 813-745-6871
Dr. Khimani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Farhad Khimani is a Blood & Marrow Transplant and Cellular therapy Physician in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Aga Khan University Medical College and has been in practice for12 years. He is experienced in bone marrow transplantation & CAR-T cell therapy and sees patient with acute myeloid leukemia, lymphoma, myeloproliferative neoplasms, and myelodysplastic syndromes for the same. He has more than 40 publications and over 300 citings.
Clinical Expertise
- Bone marrow transplantation, Acute myeloid leukemia, Lymphoma, Myeloproliferative neoplasms, Myelodysplastic syndromes , CAR-T cell therapy
Education & Training
H. Lee Moffitt Cancer CenterAdvanced Fellowship, Blood and Marrow Transplant, 2014 - 2015
West Virginia UniversityFellowship, Hematology and Medical Oncology, 2011 - 2014- West Virginia UniversityResidency, Internal Medicine, 2008 - 2011
Aga Khan Medical CollegeClass of 2005
Certifications & Licensure
FL State Medical License 2015 - 2027
WV State Medical License 2011 - 2016
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2017
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2017
Clinical Trials
- 1% Topical Pimecrolimus Cream for the Treatment of the Rash Associated With ERBITUX Start of enrollment: 2012 Feb 01
- HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide
- CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease Start of enrollment: 2019 Feb 15
Publications & Presentations
PubMed
- Expanded antigen-specific donor regulatory T cells for GVHD prevention.Joseph A Pidala, Nicoletta Cieri, Michael J Schell, Xiaofei Song, Yiren Shao
Blood. 2026-06-18 - Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).Reshma Ramlal, Jongphil Kim, Zachary Thompson, Leonel Ochoa-Bayona, Asmita Mishra
Bone Marrow Transplantation. 2026-06-01 - Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic Lymphoma.Taha Al-Juhaishi, Kwang Woo Ahn, Tiening Chen, Krina K Patel, Jinalben Patel
Transplantation and Cellular Therapy. 2026-05-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
